PBX1 genomic pioneer function drives ERα signaling underlying progression in breast cancer.
Altered transcriptional programs are a hallmark of diseases, yet how these are established is still ill-defined. PBX1 is a TALE homeodomain protein involved in the development of different types of cancers. The estrogen receptor alpha (ERα) is central to the development of two-thirds of all breast c...
Main Authors: | Luca Magnani, Elizabeth B Ballantyne, Xiaoyang Zhang, Mathieu Lupien |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2011-11-01
|
Series: | PLoS Genetics |
Online Access: | http://europepmc.org/articles/PMC3219601?pdf=render |
Similar Items
-
Identification of PBX1 target genes in cancer cells by global mapping of PBX1 binding sites.
by: Michelle M Thiaville, et al.
Published: (2012-01-01) -
Emerging role of pioneer transcription factors in targeted ERα positive breast cancer
by: Honey Pavithran, et al.
Published: (2021-02-01) -
Pioneer of prostate cancer: past, present and the future of FOXA1
by: Mona Teng, et al.
Published: (2020-09-01) -
PBX3 in Cancer
by: Richard Morgan, et al.
Published: (2020-02-01) -
YAP inhibits ERα and ER+ breast cancer growth by disrupting a TEAD-ERα signaling axis
by: Xu Li, et al.
Published: (2022-06-01)